ReviewBiomedicines2026

Reprogramming Inflammatory Macrophages with Specialized Pro-Resolving Lipid Mediators: A Novel Immunotherapeutic Strategy for Asthma.

Ruchita Tanu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.